These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 30439478)

  • 41. Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).
    Martínez-Ramírez AS; Díaz-Muñoz M; Butanda-Ochoa A; Vázquez-Cuevas FG
    Purinergic Signal; 2017 Mar; 13(1):1-12. PubMed ID: 27900516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Systematic Review of the Role of Purinergic Signalling Pathway in the Treatment of COVID-19.
    Korb VG; Schultz IC; Beckenkamp LR; Wink MR
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purinergic signalling: pathophysiology and therapeutic potential.
    Burnstock G
    Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purinergic Signaling During Immune Cell Trafficking.
    Ferrari D; McNamee EN; Idzko M; Gambari R; Eltzschig HK
    Trends Immunol; 2016 Jun; 37(6):399-411. PubMed ID: 27142306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages.
    Marques-da-Silva C; Burnstock G; Ojcius DM; Coutinho-Silva R
    Immunobiology; 2011; 216(1-2):1-11. PubMed ID: 20471713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tinkering with targeting nucleotide signaling for control of intracellular Leishmania parasites.
    Vijayamahantesh ; Vijayalaxmi
    Cytokine; 2019 Jul; 119():129-143. PubMed ID: 30909149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular purines, purinergic receptors and tumor growth.
    Di Virgilio F; Adinolfi E
    Oncogene; 2017 Jan; 36(3):293-303. PubMed ID: 27321181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extracellular creatine kinase may modulate purinergic signalling.
    Brewster LM
    Purinergic Signal; 2020 Sep; 16(3):305-312. PubMed ID: 32572751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed.
    Buvinic S; Briones R; Huidobro-Toro JP
    Br J Pharmacol; 2002 Jul; 136(6):847-56. PubMed ID: 12110609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Involvement of nucleotide receptors in the regulation of vascular function].
    Magier Z; Jarzyna R
    Postepy Biochem; 2014; 60(4):456-74. PubMed ID: 25807825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.
    Beldi G; Enjyoji K; Wu Y; Miller L; Banz Y; Sun X; Robson SC
    Front Biosci; 2008 Jan; 13():2588-603. PubMed ID: 17981736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trichomonas vaginalis NTPDase and ecto-5'-nucleotidase hydrolyze guanine nucleotides and increase extracellular guanosine levels under serum restriction.
    Menezes CB; Durgante J; de Oliveira RR; Dos Santos VH; Rodrigues LF; Garcia SC; Dos Santos O; Tasca T
    Mol Biochem Parasitol; 2016 May; 207(1):10-8. PubMed ID: 27150347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of purinergic receptors in the Alzheimer's disease.
    Cieślak M; Wojtczak A
    Purinergic Signal; 2018 Dec; 14(4):331-344. PubMed ID: 30362042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance.
    Verkhratsky A; Burnstock G
    Bioessays; 2014 Jul; 36(7):697-705. PubMed ID: 24782352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.
    Amadio S; Apolloni S; D'Ambrosi N; Volonté C
    J Neurochem; 2011 Mar; 116(5):796-805. PubMed ID: 21214557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purinergic signalling in epithelial ion transport: regulation of secretion and absorption.
    Novak I
    Acta Physiol (Oxf); 2011 Jul; 202(3):501-22. PubMed ID: 21073662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purinergic signalling: what is missing and needed next? The use of transgenic mice, crystallographic analysis and MicroRNA.
    Volonté C; Parisi C; Burnstock G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):751-67. PubMed ID: 22963439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purinergic regulation of epithelial transport.
    Bucheimer RE; Linden J
    J Physiol; 2004 Mar; 555(Pt 2):311-21. PubMed ID: 14694149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tackling Chronic Pain and Inflammation through the Purinergic System.
    Magni G; Riccio D; Ceruti S
    Curr Med Chem; 2018; 25(32):3830-3865. PubMed ID: 28699505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.